ML20217B872
| ML20217B872 | |
| Person / Time | |
|---|---|
| Issue date: | 08/29/1989 |
| From: | Norry R NRC OFFICE OF ADMINISTRATION (ADM) |
| To: | Beckjord E NRC OFFICE OF NUCLEAR REGULATORY RESEARCH (RES) |
| Shared Package | |
| ML20217B758 | List: |
| References | |
| FOIA-98-86, RULE-PRM-35-7 NUDOCS 9804230146 | |
| Download: ML20217B872 (1) | |
Text
-
Morris
- " *t,
Ba ha dur UNITED STATES Telford iI NUCLEAR REGULATORY COMMISSION
- Tse 2
wAsamorow.o c. noes File 186
/
s Pt O 28 O 1,. - oesse
- m,.
~
?', ',,,
s.1 %
/llN h
l 9 '..
kif yn '
1' MEMORANDUM FOR:
Eric S. Beckjord, Director h'
.i,
Office.of Nuclear Regulatory Research 1
i 5
i -l' FROM:
gih Patricia G. Norry, Director office of Administration I
h,
SUBJECT:
REVIEW OF THE FINAL RULE ON k{';
PALLADIUM-103 POR INTERSTITIAL R4 TREATMENT OF CANCER j
l The office of Administation concurs on the final rule that would
$~ :
amend 10 CFR Part 35 by adding palladium-103 as a sealed source in seeds to the list of brachytherapy sources permitted for use h
in the treatment of cancer.
the final rule package that presents a few additional editorialWe have 7ji corrections.
f If you have any questions concerning this matter, please call Betty K. Golden, Regulatory Publications Branch, ADM (extension 24268).
I A
Vih-J k*
Patricia G. Norry, Di ctor office of Administrat on
Enclosure:
As stated 8..v 7
r A/9 9804230146 980407 MP 8-86 PDR
~